Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do continent patients with overactive bladder respond to muscarinic receptor antagonists?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Milsom I et al. (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87: 760–766

    Article  CAS  Google Scholar 

  2. Stewart WF et al. (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20: 327–336

    CAS  PubMed  Google Scholar 

  3. Chapple CR (2002) Muscarinic receptor subtypes and management of the overactive bladder. Urology 60 (5 Suppl 1): 82–88

    Article  Google Scholar 

  4. Landis JR et al. (2004) Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. J Urol 171: 752–756

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric S Rovner.

Ethics declarations

Competing interests

Indevus – Consultant/Advisor

Pfizer – Consultant/Advisor;

Meeting Participant/Lecturer; Scientific Study/Trial

Novartis – Consultant/Advisor

Qmed – Scientific Study/Trial

Allergan – Scientific Study/Trial

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rovner, E. Do continent patients with overactive bladder respond to muscarinic receptor antagonists?. Nat Rev Urol 2, 472–473 (2005). https://doi.org/10.1038/ncpuro0301

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0301

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing